These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6210439)

  • 1. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
    Chapman HA; Vavrin Z; Hibbs JB
    Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
    Aggeler J; Risch J; Werb Z
    Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fibrinolytic inhibitor of human alveolar macrophages. Induction with endotoxin.
    Chapman HA; Stone OL
    Am Rev Respir Dis; 1985 Sep; 132(3):569-75. PubMed ID: 3898943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
    Crutchley DJ; Conanan LB
    J Biol Chem; 1986 Jan; 261(1):154-9. PubMed ID: 3079753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process.
    Gordon S; Unkeless JC; Cohn ZA
    J Exp Med; 1974 Oct; 140(4):995-1010. PubMed ID: 4427092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
    Colucci M; Paramo JA; Collen D
    J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic activity and species of plasminogen activator in human tears.
    Hayashi K; Sueishi K
    Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
    Eaton DL; Baker JB
    J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
    Chapman HA; Stone OL
    Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
    Dong Q; Zhou MH; Subbarao V; Ts'ao CH
    Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance, localization and functional properties of the cell-associated form of plasminogen activator in mouse peritoneal macrophages.
    Lemaire G; Drapier JC; Petit JF
    Biochim Biophys Acta; 1983 Feb; 755(3):332-43. PubMed ID: 6681715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.